...
首页> 外文期刊>Nature reviews. Gastroenterology & hepatology >Viral hepatitis: New strategy by which HCV evades host immune defences
【24h】

Viral hepatitis: New strategy by which HCV evades host immune defences

机译:病毒性肝炎:HCV逃避宿主免疫防御的新策略

获取原文
获取原文并翻译 | 示例
           

摘要

A functional human liver can be generated by transplanting small liver buds constructed from induced pluripotent stem cells (iPSCs) into mice, new research shows. The findings are a tentative step forward in the bid to produce laboratory-grown organs to address the critical shortage of donor organs available as treatment for end-stage organ failure. Takanori Takebe and colleagues created in vitro liver buds (an early stage in liver organogenesis) by first differentiating human iPSCs into hepatic endoderm cells and then incubating these cells with a mixture of human endothelial and mesenchymal stem cells to recapitulate what naturally occurs during early organ development. The hepatic cells self-organized into a 3D liver bud that resembled those generated in vivo. "Our approach reconstitutes the cellular interactions that are important for natural liver progression, enabling the stem cells to efficiently differentiate into hepatocytes," explains Takebe.
机译:最新研究表明,通过将由诱导性多能干细胞(iPSC)构建的小肝芽移植到小鼠中,可以产生功能正常的人肝。这些发现是为生产实验室生长的器官迈出的第一步,以解决供体器官严重不足的不足,这些器官可用于治疗晚期器官衰竭。 Takanori Takebe及其同事通过首先将人iPSC分化为肝内胚层细胞,然后将它们与人内皮和间充质干细胞混合培养,以概括早期器官发育过程中自然发生的现象,从而创造了体外肝芽(肝器官发生的早期阶段) 。肝细胞自组织成3D肝芽,类似于体内产生的肝芽。 Takebe解释说:“我们的方法重构了对自然肝脏进展至关重要的细胞相互作用,使干细胞能够有效分化为肝细胞。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号